KLF15 and renal fibrosis: Our resulting data further showed that UHRF1 contributed to progression of renal fibrosis via methylating KLF15 promotors depending on its interaction with DNMT1, implying that inhibition of UHRF1 or its interaction with DNMT1 could be a novel and effective target for the treatment of renal fibrosis.